(redirected from hairy cell leukemia)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to hairy cell leukemia: Cladribine
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for leukemia

References in periodicals archive ?
44-positive, CD 103-positive, CD25-positive, CD11c-positive, and CD123-positive cells, leading to a diagnosis of hairy cell leukemia.
When we normalized with CD19 mRNA, most of the B-NHL-other samples separated away from the MCL samples, except for several patients with hairy cell leukemia, follicular lymphoma, and diffuse large B-cell lymphoma.
We suggest that the association of hairy cell leukemia with Behcet's syndrome may not be a random occurrence.
Detection of minimal residual disease by immunostaining of bone marrow biopsics after 2-chlorodeoxyadenosine for hairy cell leukemia.
A review of the Hairy Cell Leukemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
9]/L) 70 113 Bone marrow blasts 45% 0% Dermal biopsy Sweet syndrome Sweet syndrome Associated malignancy AML Hairy cell leukemia Characteristic Case 3 Age (years) 74 Gender Female Location of rash E Duration of rash (years) 4 Body temperature ([degrees]F) 98.
Topics that will be discussed include B-cell small lymphocytic lymphoma/leukemia, lymphoplasmacytic lymphoma, extranodal marginal zone (MALT) lymphoma, follicular lymphoma, mantle cell lymphoma (MCL), hairy cell leukemia, plasmacytoma, and small T-cell proliferations.
Cloned in late 1979 and approved last summer for use against hairy cell leukemia, alpha interferon appears to cause at least partial remission 75 to 90 percent of the time, not only in patients with hairy cell leukemia (HCL), a rare disease that affects mainly men, but also in patients with chronic myelogenous leukemia (CML), a genetically caused cancer that usually lingers for more than three years before killing the patient (SN: 4/26/86, p.
Hairy Cell Leukemia Global Clinical Trials Review, H1, 2012" provides data on the Hairy Cell Leukemia clinical trial scenario.
Splenic lymphoma with villous lymphocytes (SLVL) and hairy cell leukemia (HCL) are similar-appearing B-cell neoplasms with cytoplasmic projections.
Though it was approved only for use against hairy cell leukemia, a rare white blood cell cancer, physicians can, on their own, prescribe FDA-approved drugs for any condition.
Pestka was the first to develop a genetically engineered biotherapeutic, the interferon-based drug Roferon A, in 1986 for treatment of hairy cell leukemia.
Ibrutinib, which goes by the trade name Imbruvica(TM), is a therapy that targets an enzyme, Bruton's tyrosine kinase (BTK), which promotes growth of a variety of B-cell cancers, including CLL, MCL, Waldenstrom's macroglobulinemia (WM), follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), hairy cell leukemia (HCL) and multiple myeloma.
Pink Sheets: TROV), a developer of transrenal molecular diagnostics to facilitate personalized medicine, has signed a worldwide exclusive license for an assay that detects Hairy Cell Leukemia (HCL).